Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer

BACKGROUND: The prognosis of patients with advanced gastric cancer is poor. The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer. METHODS: For patients in the experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhan-Dong, Kong, Ye, Yang, Wei, Zhang, Bin, Zhang, Yong-Lei, Ma, Er-Min, Liu, Hong-Xing, Chen, Xiao-Bin, Hua, Ya-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020605/
https://www.ncbi.nlm.nih.gov/pubmed/24758484
http://dx.doi.org/10.1186/1477-7819-12-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020605/
https://www.ncbi.nlm.nih.gov/pubmed/24758484
http://dx.doi.org/10.1186/1477-7819-12-115

Ejemplares similares